Tesla Stock Surges Amid EV Growth Hopes and Regulatory Changes

Tesla (TSLA) stock surged on Monday, adding to its nearly 13% gain from last week, as the electric vehicle giant sets its sights on a price level it hasn’t reached since early 2022. The company’s shares jumped to 389.79, advancing 0.15% after hitting a high of 404.80 earlier in the day. Tesla is optimistic about … Read more

Fury vs Usyk II: Tyson Fury Ready for Rematch with Intense Training

Tyson Fury is set to face Oleksandr Usyk at the Kingdom Arena in Riyadh on December 21, a rematch of their intense first bout. The heavyweight giants are both in top shape, having finished training to head into the fight as the best versions of themselves. Fury recently revealed his intense training efforts on Instagram, … Read more

S&P 500 Sees Bullish Outlook for Record Rally Past 7,100

Oppenheimer Asset Management is forecasting a record-setting rally for the S&P 500 by year-end 2024, with some strategists predicting the index will surpass 7,100. The firm’s Chief Investment Strategist John Stoltzfus says fundamentals suggest the economy and stock market will continue to grow into next year. Stoltzfus points to strong economic growth, a rate-cutting cycle, … Read more

Putin Urged to Ceasefire in Ukraine as Assad Regime Falls

US President-elect Donald Trump has urged Russian leader Vladimir Putin to agree to an immediate ceasefire in Ukraine before the conflict escalates further. With the regime of his Syrian ally Bashar al-Assad toppled, Trump warned that Russia should focus its resources on ending the war in Ukraine. Assad’s departure from Damascus means the end of … Read more

Russia Grants Asylum to Syrian President al-Assad Amid Conflict Concerns

Russia has granted asylum to deposed Syrian President Bashar al-Assad, according to Kremlin spokesman Dmitry Peskov. The decision was made personally by President Vladimir Putin and comes amid concerns over Russian military bases in Syria. Al-Assad was allegedly evacuated from a Russian airbase in Latakia on a Russian plane, sparking questions about the impact of … Read more

“New Study Reveals Hidden Benefits of Reading”

A recent study has shed new light on the benefits of reading, suggesting that it can have a significant impact on both physical and mental health. The research, which analyzed data from over 10,000 participants, found that readers experienced lower blood pressure, cholesterol levels, and body mass index compared to non-readers. In addition to these … Read more

4 Lifestyle Changes to Boost Brain Health

A neurosurgeon has shared four simple lifestyle changes to help keep your brain healthy and reduce the risk of dementia. According to Dr. Rahul Jandial, leading neurosurgeon and author, these habits can make a significant difference in our cognitive function as we age. Dr. Jandial’s top tips include: 1. Eating a Mediterranean ‘mind diet’ rich … Read more

Global Markets See Mixed Results Amid Rate Hikes and Cuts

Global markets experienced a mixed bag of results last week, with the US stock market yielding mixed outcomes. The Dow Jones fell 0.60%, while the Nasdaq surged 3.34%. The S&P 500 bucked the trend, rising 0.96%. In Europe, indices showed an uptrend, with the FTSE 100 in the UK up 0.26%, DAX 30 in Germany … Read more

Scientists Weigh Odds of Alien Life Beyond Earth

Are we searching for life in the right place? A recent study suggests our own universe might not be suitable for star formation, making the emergence of alien civilizations unlikely. Researchers propose that parallel universes within the multiverse may offer better chances. Not all aliens need planets to survive. Free-floating colonies could thrive in space … Read more

Sanofi Unveils Promising Phase III Results for Rilzabrutinib

Sanofi has announced positive Phase III results for rilzabrutinib, an oral Bruton’s tyrosine kinase (BTK) inhibitor in development for immune thrombocytopenia (ITP). The French pharmaceutical company tested the treatment in adults with ITP and observed a significant improvement in platelet counts. Patients on rilzabrutinib showed a median time to first platelet response of 36 days, … Read more